established the largest Chinese cohort of sporadic CCM, where among 94 patients with CCM, 44 had CCM1/CCM2 or MAP3K3 mutations, with 75% also having concurrent PIK3CA mutations. The gene discussed is CCM2; the disease is cerebral cavernous malformation.